Oasys Now competed for the ultimate prize in opposition to Irish-based DevA11y and Mohana, a Canadian start-up.
Dutch medtech start-up Oasys Now has gained this 12 months’s Slush 100 competitors, taking house a €1m fairness funding from two outstanding early-stage enterprise funds – Normal Catalyst and Cherry Ventures.
The successful start-up, which has developed an AI-powered scientific trial affected person identification and recruitment platform, may also obtain mentoring from business leaders to scale up its enterprise.
In response to the corporate’s co-founder Nima Salami, a former bioinformatics researcher on the Delft College of Know-how, Oasys Now’s mission is to “allow each particular person to leverage their distinctive well being knowledge to stop or heal illness”.
Based in 2021 by Salami – who’s an Iranian refugee – and Sara Okhuijsen, an knowledgeable in DNA and precision medication, Oasys Now could be constructing the EU’s first AI-powered affected person recruitment platform for scientific trials.
The platform consists of two merchandise; a GRIP app that gives customers private well being insights and permits them to see related scientific trials obtainable to them and the ELaiGIBLE platform, aimed toward hospitals and clinics which hurries up the method of discovering eligible affected person cohorts for scientific trials from “months to minutes”.
The AI-powered scientific trial administration market is profitable, value almost $1.8bn in 2024, and the market is predicted to develop to just about $5bn earlier than the tip of the last decade.
Salami based the corporate due to the challenges his mom confronted as a refugee with persistent sickness. “In each new nation we arrived in, Anna [Salami’s mother] needed to undergo a whole re-diagnosis earlier than receiving the popularity of her illness and the suitable look after it,” Salami mentioned.
“Pissed off by this expertise, I set out on a mission to construct a greater affected person journey that might assist sufferers, healthcare suppliers and researchers worldwide.”
Oasys Now will use its winnings to develop its staff and improve compute energy for its companies.
The three-year-old Dutch start-up fought for this 12 months’s prize in opposition to Eire-based DevA11y, a start-up working in the direction of digital accessibility and Canadian Mohana, a platform aiming to assist girls higher perceive their perimenopausal signs.
A former Begin-up of the Week, DevA11y goals to make constructing accessible merchandise straightforward for companies – opening the digital world to extra folks, no matter their disabilities.
Based in 2023 by Dóra Jámbor, Mohana is a precision platform to assist girls scale back the effort and time required to detect, perceive and act on hormonal imbalances.
Eire had a powerful presence at Slush this 12 months, with Enterprise Eire taking a 24-company delegation to the occasion in Finland which included included Manna Drone Supply, office wellbeing start-up Lua Well being and knowledge safety firm Binarii Labs.
Final 12 months, Faircado, a Berlin-based ecommerce platform gained the Slush 100 competitors for its browser extension resolution that finds second-hand options for the merchandise customers need to purchase.
Don’t miss out on the data you want to succeed. Join the Every day Temporary, Silicon Republic’s digest of need-to-know sci-tech information.
